Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome

(2015) Evangelos Giamarellos-Bourboulis et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

267 The First Large Scale Deep Sequencing of the Duodenal Microbiome in Irritable Bowel Syndrome Reveals Striking Differences Compared to Healthy Controls

(2015) Mark Pimentel et al.   GASTROENTEROLOGY

Tu2029 Deep Sequencing Reveals That the Microbiome of the Human Duodenum Is Unique and Unrelated to Stool Bacterial Profiling

(2015) Christopher Chang et al.   GASTROENTEROLOGY

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

(2014) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome

(2014) Mark Pimentel et al.   DIGESTIVE DISEASES AND SCIENCES

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth

(2014) Aikaterini Pistiki et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rifaximin: beyond the traditional antibiotic activity

(2014) Fiorella Calanni et al.   JOURNAL OF ANTIBIOTICS

Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations

(2014) E.A. Debbia et al.   JOURNAL OF CHEMOTHERAPY

Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients

(2014) Satya Vati Rana et al.   Journal of Crohns & Colitis

GP perspectives of irritable bowel syndrome – an accepted illness, but management deviates from guidelines: a qualitative study

(2013) Elaine F Harkness et al.   BMC Family Practice

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

(2013) Dabo Xu et al.   GASTROENTEROLOGY

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

(2012) P. Meyrat et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Evaluation of Harm in the Pharmacotherapy of Irritable Bowel Syndrome

(2012) Eric Shah et al.   AMERICAN JOURNAL OF MEDICINE

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

(2012) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites

(2012) Georgios N. Kalambokis et al.   Clinical Gastroenterology and Hepatology

The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome

(2012) Emmannouil Pyleris et al.   DIGESTIVE DISEASES AND SCIENCES

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

(2012) I. M. Carroll et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Pregnane X receptor as a target for treatment of inflammatory bowel disorders

(2012) Jie Cheng et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

(2011) Stacy B Menees et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

(2011) Mirjana Rajilić–Stojanović et al.   GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin in the treatment of inflammatory bowel disease

(2011) Mario Guslandi   WORLD JOURNAL OF GASTROENTEROLOGY

Evaluating a Bacterial Hypothesis in IBS Using a Modification of Koch’s Postulates: Part 1

(2010) Mark Pimentel   AMERICAN JOURNAL OF GASTROENTEROLOGY

Bile Acids Improve the Antimicrobial Effect of Rifaximin

(2010) C. Darkoh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroAntimicrobial Susceptibility of Bacterial Enteropathogens Isolated from International Travelers to Mexico, Guatemala, and India from 2006 to 2008

(2010) Jeannette Ouyang-Latimer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Abnormal Breath Testing in IBS: A Meta-Analysis

(2010) Eric D. Shah et al.   DIGESTIVE DISEASES AND SCIENCES

Pharmacotherapy for Hepatic Encephalopathy

(2010) Paula V. Phongsamran et al.   DRUGS

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

(2010) Zhi-Dong Jiang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles

(2009) E. L. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

(2009) Alexander C. Ford et al.   Clinical Gastroenterology and Hepatology

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

(2009) Angèle PM Kerckhoffs et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Elevated pro-inflammatory and lipotoxic mucosal lipidscharacterise irritable bowel syndrome

(2009) Kajsa Kajander et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Patients' explanatory models for irritable bowel syndrome: symptoms and treatment more important than explaining aetiology

(2008) R. E Casiday et al.   FAMILY PRACTICE

T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response

(2008) Anthony Lembo et al.   GASTROENTEROLOGY